VGK
Search documents
Should You Add More U.K. ETFs to Your Portfolio Now?
ZACKS· 2026-02-20 17:01
Core Insights - The FTSE 100 has shown strong performance in 2026, rising 7.69% year-to-date and 22.75% over the past year, outperforming the S&P 500, which is down 0.24% year-to-date but up 12.16% over the past year [1][10] Market Trends - Rising geopolitical tensions and U.S. market volatility related to AI concerns have led investors to reassess their U.S. exposure and shift away from American securities [2][3] - The "AI scare" has heightened investor anxiety, particularly affecting the S&P 500 due to its heavy concentration in the information technology sector, prompting a rotation away from U.S. equities [3] Sector Performance - The FTSE 100 benefits from a heavier weighting in banks and mining stocks, with limited exposure to big tech and AI-driven companies, contributing to its outperformance compared to the S&P 500 [4] - U.K. large caps are trading at approximately a 40% valuation discount relative to U.S. equities, with U.K. banks showing compelling valuations compared to U.S. peers [5] Economic Indicators - The S&P Global U.K. Composite PMI rose to 53.9 in February, indicating continued economic momentum, marking the strongest level since April 2024 [6] - U.K. retail sales saw a 4.5% year-over-year increase in January, the strongest annual gain in almost four years [7] - The U.K. recorded a £30.4 billion ($40.9 billion) budget surplus in January 2026, a significant improvement from the previous year [8] Inflation and Monetary Policy - U.K. inflation eased to 3.0% in January, the lowest since March 2025, raising expectations for a potential interest rate cut by the Bank of England [9][10] - Following the inflation data, market expectations for a March rate cut by the Bank of England increased to nearly 90% [10][11] Investment Opportunities - Investors can consider U.K. ETFs such as iShares MSCI United Kingdom ETF (EWU) and Franklin FTSE United Kingdom ETF (FLGB) for increased exposure to the U.K. market [12] - Other diversified ETFs with significant U.K. exposure include iShares MSCI Europe Small-Cap ETF (IEUS) and iShares Core MSCI Europe ETF (IEUR) [13]
European ETFs in Spotlight Following Trump's Tariff Retreat at Davos
ZACKS· 2026-01-22 15:50
Core Insights - The global stock market experienced significant volatility due to U.S. President Trump's threats of new protectionist measures against European allies, particularly concerning tariffs of 10% to 25% on eight European nations and potential duties of up to 200% on French exports [1][3] - A pivotal meeting at the World Economic Forum led to Trump retracting his tariff threats, announcing a "framework deal" for Arctic security, which alleviated immediate trade war concerns [2][4] - The easing of tariff threats has created a favorable environment for European Exchange-Traded Funds (ETFs), as the removal of trade uncertainty serves as a catalyst for a relief rally in European assets [3][6] Market Reactions - Following Trump's announcement, the pan-European Stoxx 600 index rose nearly 1.2%, with major indices like the FTSE 100 and France's CAC 40 also showing gains of 0.74% and 1.3% respectively [4] - The U.S. S&P 500 Index and Nasdaq Composite both recorded a 1.2% gain, indicating a rebound across transatlantic equities as trade uncertainties were alleviated [5] European ETFs Focus - European ETFs are highlighted as an efficient means to capitalize on the current relief rally, providing exposure to a broad recovery in the Eurozone's industrial and consumer sectors, which were heavily impacted during the tariff scare [6][7] - Specific European ETFs are recommended for investors seeking renewed exposure to Europe while maintaining liquidity and diversification, including: - **SPDR EURO STOXX 50 ETF (FEZ)**: AUM of $5.22 billion, top holdings include ASML (10.32%), SAP (4.61%), Siemens (4.45%) [8][10] - **iShares MSCI Eurozone ETF (EZU)**: AUM of $9.39 billion, top holdings include ASML (6.96%), SAP (3.19%), Siemens (3.03%) [11] - **Vanguard FTSE Europe ETF (VGK)**: AUM of $37.1 billion, top holdings include ASML (2.81%), Roche (1.92%), AstraZeneca (1.84%) [12]